Table 4.
Comparison of our results of alleles frequencies obtained in the control group with other publications performed in Turkish population.
| Our results | Gunes et al. [36] n = 150 |
Dayangac-Erden et al. [34] n = 100 |
Toptaş et al. [33] n = 122 |
Gogas Yavuz et al. [26] n = 134 |
Buyru et al. [32] n = 27 |
Cakir et al. [37] n = 70 |
Kılıç et al. [41] n = 96 |
||
|---|---|---|---|---|---|---|---|---|---|
| ApaI | A | 0.60 | 0.37 | 0.57 | — | 0.65 | — | 0.614 | 0.54 |
| rs7975232 | C | 0.40 | 0.63 | 0.425 | — | 0.35 | — | 0.386 | 0.46 |
| FokI | T | 0.70 | — | 0.73 | 0.717 | 0.84 | — | 0.736 | 0.68 |
| rs2228570 | C | 0.30 | — | 0.27 | 0.283 | 0.16 | — | 0.264 | 0.32 |
| rs10735810 | |||||||||
| TaqI | A | 0.62 | 0.65 | 0.595 | 0.731 | 0.65 | 0.615 | 0.65 | 0.65 |
| rs731236 | C | 0.38 | 0.35 | 0.405 | 0.273 | 0.35 | 0.384 | 0.35 | 0.35 |
| Significancy in disease | No significancy in Behçet's and neuro-Behçet's disease | No significancy in urolithiasis | TaqI in psoriasis |
No significancy in brain cancer | No significancy in type 1 diabetes | No significancy in breast cancer | No significancy in nephrolithiasis | No significancy in atopic dermatitis |